• BICO

  • Jacob Thordenberg

Jacob Thordenberg

Chief Financial Officer at BICO

Jacob Thordenberg has a solid work history in the field of finance and M&A. Jacob is currently serving as the Chief Financial Officer at BICO, a bioconvergence company specializing in 3D cell culture and tissue printing. Prior to this, they held the position of Head of M&A & Investments at BICO. Before joining BICO, Jacob worked at Telia Company, a Nordic and Baltic telecommunications and media company, where they held the role of Director of Group M&A and Manager of Group M&A. Jacob also gained experience at Deloitte, where they worked as a Manager in M&A Transaction Services, specializing in financial due diligence for private equity funds and large corporations. Throughout their career, Jacob has demonstrated expertise in financial analysis, deal assessment, and cross-border projects.

Jacob Thordenberg received their education as follows:

- From 2009 to 2010, they attended Lund University and obtained a Master of Science (M.S.) degree in Corporate and Financial Management.

- In 2008 to 2009, they studied at the University of Leeds and earned an Ekonomie kandidatexamen (ek.kand.) degree, focusing on elective credits within their Bachelor in Finance.

- Between 2006 and 2009, they pursued their undergraduate studies at Lund University and graduated with a Bachelor of Science (BS) degree in Accounting and Corporate Finance.

- In 2004 and 2005, they attended Santa Barbara City College and completed a Certificate in Business Administration.

- Lastly, from 2001 to 2004, they studied at Östra Real Gymnasium, specializing in the Social Science Programme with a focus on Business Administration.

Location

Stockholm, Sweden

Links

Previous companies


Org chart


Teams


Offices

This person is not in any offices


BICO

3 followers

BICO is a life science tools company offering life science tools that enable human organ and tissue production. By combining different technologies, such as robotics, artificial intelligence, computer science, and 3D bioprinting with biology. They focus on the ecosystems of bioprinting, multi-omics, cell line development, and diagnostics. Thecompany develops and markets technologies that enable researchers in the life sciences to print human tissues, perform drug screening and develop diagnostic solutions.


Employees

1,001-5,000

Links